Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g. NEAR(recruit, professionals, 20)).
Finds documents with the search term in word versions or composites. The asterisk * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g. lightweight*, *lightweight, *lightweight*).
Review the latest trials of immune checkpoint inhibitors, vaccine therapy, oncolytic viruses, and CAR T-cell therapy, and the neurological toxicities and physiological barriers that make treating CNS tumors uniquely challenging.
Drug-induced interstitial lung disease has emerged as a clinically significant complication in the era of immunotherapy and biologics. Learn how to diagnose and manage this potentially severe adverse event.
Data from a large cohort has revealed a significant association between higher consumption of certain food preservatives and an increased incidence of cancer and type 2 diabetes.
Glucocorticoids are cornerstone agents in oncology due to their potent anti-inflammatory, immunosuppressive, and antitumor properties. But it is is crucial to strike a balance between therapeutic benefit and harm.
Adjuvant treatment for metastatic melanoma with six cycles of nivolumab also led to a sustained response of the concurrent early-stage gastric cancer in this patient, who achieved long-term disease-free survival with minimal treatment.
Learn more about the importance of adapting treatment approaches for special patient populations (eg, elderly or pregnant patients) in this third module of our interactive e-Learning program on diagnosing and treating aplastic anemia.
Are you up to date on targeted therapies for relapsed/refractory AML?
Join Prof. Amer Zeidan and his expert guests to hear about innovations in molecular testing, emerging therapies, and IDH-targeted treatments, and get practical advice for improving your patient care.
Supported by: independent educational grant from Rigel
Join Professor Joy Ho as she leads a panel of Asia-Pacific-based experts, discussing real-life patient cases and their experiences with CAR T-cell therapy for the treatment of R/R DLBCL or R/R FL. Learn about how to identify appropriate patients for CAR T-cell therapy and how to optimize outcomes with this treatment modality. Gain insights into essential aspects of pre- and post-infusion management, as well as important considerations for treatment sequencing.
This educational activity is not intended for healthcare professionals based in the UK, US, or off-label Asia-Pacific countries.
Adjuvant treatment for metastatic melanoma with six cycles of nivolumab also led to a sustained response of the concurrent early-stage gastric cancer in this patient, who achieved long-term disease-free survival with minimal treatment.
Colonic leiomyosarcoma is a rare and aggressive tumor that is often difficult to diagnose preoperatively, especially in a case such as this where multiple biopsies were inconclusive.
A case illustrating a rare but important association between Behçet disease and Hodgkin lymphoma, possibly mediated by immune dysregulation and chronic immunosuppression.
CRC remains a major global health burden, but advances in screening, treatment, and lifestyle-based prevention continue to reshape clinical practice. Gain insights into how the latest research can be leveraged to optimize patient care across the CRC continuum.
Thyroid eye disease (TED) is the most common cause of orbital disease. TED most commonly arises due to Graves’ disease, however, may occur in hypothyroidism and euthyroid states. These thyroid disorders are typically de novo autoimmune processes …
The advent of next-generation sequencing (NGS) has significantly advanced the classification of mesenchymal neoplasms, allowing for the identification of novel gene fusion–driven entities, also in the cutaneous setting. These molecular discoveries …
Triple-negative breast cancer (TNBC) is an aggressive and heterogeneous disease with limited treatment options. Antibody–drug conjugates (ADCs), particularly those targeting trophoblast cell-surface antigen 2 (Trop‑2), have emerged as an effective …
Marking a major milestone in chronic myeloid leukemia treatment
Tyrosine kinase inhibitors have transformed the treatment of chronic myeloid leukemia, a condition that had limited therapeutic options before.
In this 25th year since the first phase 2 trials of the first TKI, we speak to a researcher and clinician who has been involved since the early days. Dr. Jorge Cortes shares his experience and talks about the impact of these drugs, not only in the treatment of CML but also more widely.
Professor Joy Ho and a panel of Asia-Pacific-based experts will examine real-life patient cases in this Masterclass, exchanging insights into their clinical experiences of using CAR T-cell therapy to treat patients with R/R DLBCL or R/R FL.
This educational activity is not intended for healthcare professionals based in the UK, US, or off-label Asia-Pacific countries.
This hub presents a curated selection of educational materials focused on the latest clinically relevant topics related to the use of chimeric antigen receptor (CAR) T‑cell therapy for the treatment of relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) and R/R follicular lymphoma (FL).
This content has been developed in collaboration with and funded by the sponsor Novartis Pharma AG and is not intended for healthcare professionals based in the UK and US.
Hear directly from experts in acute myeloid leukemia about innovations in molecular testing, emerging therapies, and targeted treatments, and get practical advice for improving the care of your patients with relapsed or refractory disease.
Breast imaging is essential for detecting breast cancer, but it also identifies a range of findings beyond malignant lesions, including benign and indeterminate lesions. The latter, also known as “B3 lesions” according to European and UK …
Thyroid eye disease (TED) is the most common cause of orbital disease. TED most commonly arises due to Graves’ disease, however, may occur in hypothyroidism and euthyroid states. These thyroid disorders are typically de novo autoimmune processes …
Testicular germ-cell tumors (TGCT) are the most common solid malignancy in young men and a paradigm of curable cancer. Around two-thirds to three-quarters present with clinical stage I disease, where long-term cancer-specific survival (CSS) …
Among people with cancer, the presence of fatigue before starting treatment is associated with an increased risk for severe, life-threatening, or fatal adverse events.
Review the latest trials of immune checkpoint inhibitors, vaccine therapy, oncolytic viruses, and CAR T-cell therapy, and the neurological toxicities and physiological barriers that make treating CNS tumors uniquely challenging.